共 18 条
[2]
Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)[J] . Elaine M. Dennison,Juliet E. Compston,Julie Flahive,Ethel S. Siris,Stephen H. Gehlbach,Jonathan D. Adachi,Steven Boonen,Roland Chapurlat,Adolfo Díez-Pérez,Frederick A. Anderson,Frederick H. Hooven,Andrea Z. LaCroix,Robert Lindsay,J. Coen Netelenbos,Johannes Pfeilschifter,Maurizio Rossini,Christian Roux,Kenneth G. Saag,Philip Sambrook,Stuart Silverman,Nelson B. Watts,Susan L
[3]
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary[J] . Papaioannou,Alexandra,Morin,Suzanne,Cheung,Angela M,Atkinson,Stephanie,Brown,Jacques P,Feldman,Sidney,Hanley,David A,Hodsman,Anthony,Jamal,Sophie A,Kaiser,Stephanie M,Kvern,Brent,Siminoski,Kerry,Leslie,William D.Canadian Medical Association. Journal . 2010 (17)
[4]
Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—Conformity between methods and their clinical utility[J] . W. Pluskiewicz,P. Adamczyk,E. Franek,P. Leszczynski,E. Sewerynek,H. Wichrowska,L. Napiorkowska,T. Kostyk,M. Stuss,W. Stepien-Klos,K.S. Golba,B. Drozdzowska.Bone . 2010 (6)
[6]
Prognosis of fracture: evaluation of predictive accuracy of the FRAX? algorithm and Garvan nomogram[J] . S. K. Sandhu,N. D. Nguyen,J. R. Center,N. A. Pocock,J. A. Eisman,T. V. Nguyen.Osteoporosis International . 2010 (5)
[7]
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX ?[J] . John A. Kanis,Helena Johansson,Anders Oden,Eugene V. McCloskey.Bone . 2009 (6)
[8]
FRAX ? and its applications to clinical practice[J] . Bone . 2009 (5)
[9]
Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study[J] . E. V. McCloskey,H. Johansson,A. Oden,S. Vasireddy,K. Kayan,K. Pande,T. Jalava,J. A. Kanis.Osteoporosis International . 2009 (5)
[10]
Case finding for the management of osteoporosis with FRAX ? —assessment and intervention thresholds for the UK[J] . J. A. Kanis,E. V. McCloskey,H. Johansson,O. Strom,F. Borgstrom,A. Oden.Osteoporosis International . 2008 (10)